Data availability statement
The data that supports the findings of this study are available within the material of this article and the supplementary material.
References
Berna R, Rosenbach M, Margolis DJ, Mitra N, Baumrin E. Methotrexate cutaneous ulceration: a systematic review of cases. Am J Clin Dermatol. 2022;23(4):449–57. https://doi.org/10.1007/s40257-022-00692-1.
Bedoui Y, Guillot X, Sélambarom J, Guiraud P, Giry C, Jaffar-Bandjee MC, et al. Methotrexate an old drug with new tricks. Int J Mol Sci. 2019;20(20):5023. https://doi.org/10.3390/ijms20205023.
Weinstein GD, Frost P. Methotrexate for psoriasis: a new therapeutic schedule. Arch Dermatol. 1971;103(1):33–8. https://doi.org/10.1001/archderm.1971.04000130035004.
Gyulai R, Bagot M, Griffiths CEM, Luger T, Naldi L, Paul C, et al. Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists. J Eur Acad Dermatol Venereol. 2015;29(2):224–31. https://doi.org/10.1111/jdv.12495.
Arnet I, Bernhardt V, Hersberger KE. Methotrexate intoxication: the pharmaceutical care process reveals a critical error. J Clin Pharm Ther. 2012;37(2):242–4. https://doi.org/10.1111/j.1365-2710.2011.01263.x.
Pradhan S, Sirka CS, Rout AN, Dash G, Sahu K. Acute methotrexate toxicity due to overdosing in psoriasis: a series of seven cases. Indian Dermatol Online J. 2019;10(1):64–8. https://doi.org/10.4103/idoj.IDOJ_157_18.
Vial T, Patat AM, Boels D, Castellan D, Villa A, Theophile H, Torrents R, et al. Adverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers. Jt Bone Spine. 2019;86(3):351–5. https://doi.org/10.1016/j.jbspin.2018.09.006.
Cairns R, Brown JA, Lynch AM, Robinson J, Wylie C, Buckley NA. A decade of Australian methotrexate dosing errors. Med J Aust. 2016;204(10):384. https://doi.org/10.5694/mja15.01242.
Radmanesh M, Rafiei B, Moosavi ZB, Sina N. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial. Int J Dermatol. 2011;50(10):1291–3. https://doi.org/10.1111/j.1365-4632.2011.04967.
Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today. 2016;21(4):648–53. https://doi.org/10.1016/j.drudis.2016.02.015.
Pharmacovigilance Risk Assessment Committee. PRAC recommends new measures to avoid dosing errors with methotrexate. European Medicines Agency. 2019. https://www.ema.europa.eu/en/news/prac-recommends-new-measures-avoid-dosing-errors-methotrexate. Accessed 5 Jan 2023.
Conn VS, Ruppar TM, Chan KC, Dunbar-Jacob J, Pepper GA, De Geest S. Packaging interventions to increase medication adherence: systematic review and meta-analysis. Curr Med Res Opin. 2015;31(1):145–60. https://doi.org/10.1185/03007995.2014.978939.
Institute for Safe Medication Practices. Call to action: longstanding strategies to prevent accidental daily methotrexate dosing must be implemented. Institute for Safe Medication Practices; 2018. https://www.ismp.org/resources/call-action-longstanding-strategies-prevent-accidental-daily-methotrexate-dosing-must-be. Accessed 10 Jan 2023.
Author information
Authors and Affiliations
Contributions
Dayna Diven: conceptualized the project and provided edits. Adam Olesen: edited the paper, gave suggestions for references, and reformatted the paper. Aarthi Parvathaneni: Primary writter of the paper.
Corresponding author
Ethics declarations
Funding
No sources of funding were used to assist in the preparation of this article.
Conflicts of interest
Aarthi Parvathaneni, Adam Olesen, and Danya Diven have no conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Parvathaneni, A., Olesen, A. & Diven, D. Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”. Am J Clin Dermatol 24, 487–489 (2023). https://doi.org/10.1007/s40257-023-00773-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-023-00773-9